|
Tables
|
Table 7a. Novo Nordisk's products manufactured using
genetic engineering
|
|
|
|
|
Pharmaceuticals
|
Application
|
|
GlucaGen®HypoKit
|
Hypoglycaemia
|
|
Human insulin
|
Diabetes
|
|
Norditropin®
|
Human growth
hormone deficiency
|
|
NovoSeven®
|
Haemophilia
|
|
|
|
|
Enzymes
|
Application
|
|
Alpha-GalTM
|
Animal Feed
|
|
AquazymTM Ultra
|
Textile Industry
|
|
Bio-FeedTM Wheat
|
Animal Feed
|
|
Carezyme®
|
Detergent Industry
|
|
Cellusoft® Ultra
|
Textile Industry
|
|
Denimax® Ultra
|
Textile Industry
|
|
DurazymTM
|
Detergent Industry
|
|
Greasex®
|
Leather Industry
|
|
Lipolase®
|
Detergent Industry
|
|
Lipolase Ultra
|
Detergent Industry
|
|
Lipozyme® IM
|
Interesterification
|
|
LiquozymeTM
|
Distilling Industry
|
|
Maltogenase®
|
Starch Industry
|
|
MaturexTM
|
Brewing Industry
|
|
Novamyl®
|
Baking Industry
|
|
NovoCorTMAD
|
Leather Industry and
Organic Synthesis
|
|
Novozym® 388
|
Organic Synthesis
|
|
Novozym 435
|
Ester Synthesis
|
|
Novozym 525
|
Organic Synthesis
|
|
Novozym 677
|
Baking Industry
|
|
PentopanTMMono
|
Baking Industry
|
|
PulpzymeTMHC
|
Pulp & Paper Industry
|
|
Relase®
|
Detergent Industry
|
|
Resinase®
|
Pulp & Paper Industry
|
|
Savinase®
|
Detergent Industry
|
|
Termamyl®
|
Starch, Detergent and
Textile Industries
|
|
ThermozymeTM
|
Textile Industry
|
|
| Table 7b. Reduced consumption of resources from genetic engineering. |
| The figures state an index for consumption per metric ton of enzyme produced based on the conventional production organism. |
|
| Conventional microorganism |
Raw materials |
Water |
Steam |
Electricity |
|
(weight) |
(weight) |
(weight) |
(kWh) |
| Fermentation |
65 |
36 |
26 |
75 |
| Recovery |
35 |
64 |
74 |
25 |
| TOTAL |
100 |
100 |
100 |
100 |
|
| Genetically-modified microorganism |
Raw materials |
Water |
Steam |
Electricity |
| Fermentation |
32 |
18 |
13 |
38 |
| Recovery |
27 |
35 |
39 |
13 |
| TOTAL |
59 |
53 |
52 |
51 |
| Percentage saved |
41% |
47% |
48% |
49% |
|
| Table 8. improved supply reliability from genetic engineering. |
| |
1994 |
2004 |
| Total world insulin requirement (million units) |
*162,000 |
**250,000 |
| Total world insulin requirement (kg) |
5,700 |
8,800 |
| Yield after recovery (mg/kg pig glands) |
100 |
100 |
| Number of pig glands per kg |
8 |
8 |
Number of pigs necessary to cover the world requirement
for insulin produced by the traditional method# |
460,000,000 |
710,000,000 |
|
| * Figures based on IMS (Intercontinental Medical Systems). |
| ** Novo Nordiskšs estimate. |
| # For comparison, according to the Danish Meat Research Institute, worldwide production is approx. 1,300,000,000 pigs for slaughtering, but in practice only a fraction of this number is available due to decentralized slaughtering processes and long transport distances. |
|
|
